Person:
Calvo Lobo, César

First Name

César

Last Name

Calvo Lobo

URI

https://hdl.handle.net/20.500.14352/77222

Affiliation

Universidad Complutense de Madrid

Faculty / Institute

Enfermería, Fisioterapia y Podología

Department

Enfermería

Area

Fisioterapia

Identifiers

Full item page

Search Results

Now showing 1 - 10 of 23

Biomarkers and Nutrients in Musculoskeletal Disorders
(Nutrients, 2021) Calvo Lobo, César; Becerro de Bengoa Vallejo, Ricardo; Losa Iglesias, Marta Elena; Rodríguez Sanz, David; López López, Daniel; San Antolín, Marta
Worldwide, the burden of musculoskeletal disorders is increasing with great variations between-countries, which makes it difficult for policymakers to provide resources and adequate interventions in order to provide for their appropriate management. Thus, musculoskeletal disorders remain a public health problem and their incidence and trend is increasing for some specific conditions. Indeed, nutrients and biological biomarkers play a key role in the prognosis, diagnosis and health status of patients suffering from musculoskeletal conditions, being the main indicators for understanding biological processes as well as tailoring therapeutic interventions and nutritional programs in patients with musculoskeletal disorders. Thus, the purpose of this Special Issue was to provide an update on the state of the art, through current reviews as well as new insights and interventions, about the main role of nutrients and biomarkers in patients who suffer from musculoskeletal conditions from a multidisciplinary point of view.
Concurrent Validity and Reliability of Manual Versus Specific Device Transcostal Measurements for Breathing Diaphragm Thickness by Ultrasonography in Lumbopelvic Pain Athletes.
(Sensors (Basel, Switzerland), 2021) Marugán Rubio, Daniel; Chicharro, Jose L; Becerro de Bengoa Vallejo, Ricardo; Losa Iglesias, Marta Elena; Rodríguez Sanz, David; Vicente Campos, Davinia; Dávila Sánchez, Gabriel J; Calvo Lobo, César
The use of rehabilitative ultrasound imaging (RUSI) to evaluate diaphragm thickness during breathing in athletes who suffer from non-specific lumbopelvic pain presents some measurement errors. The purpose of this study was to evaluate intra- and inter-sessions, intra- and inter-rater reliabilities, and concurrent validity of diaphragm thickness measurements during breathing using transcostal RUSI with a novel thoracic orthotic device that was used to fix the US probe versus those measurements obtained using manual fixation. A total of 37 athletes with non-specific lumbopelvic pain were recruited. Intra- (same examiner) and inter-rater (two examiners) and intra- (same day) and inter-session (alternate days) reliabilities were analyzed. All measurements were obtained after manual probe fixation and after positioning the thoracic orthotic device to fix the US probe in order to correctly correlate both measurement methods. Both left and right hemi-diaphragm thickness measurements were performed by transcostal RUSI at maximum inspiration, expiration, and the difference between the two parameters during relaxed breathing. Intra-class correlation coefficients (ICC), standard errors of measurement (SEM), minimum detectable changes (MCD), systematic errors, and correlations () were assessed. Orthotic device probe fixation showed excellent reliability (ICC = 0.852-0.996, SEM = 0.0002-0.054, and MDC = 0.002-0.072), and most measurements did not show significant systematic errors ( > 0.05). Despite manual probe fixation with a reliability ranging from good to excellent (ICC = 0.714-0.997, SEM = 0.003-0.023, and MDC = 0.008-0.064 cm), several significant systematic measurement errors ( < 0.05) were found. Most significant correlations between both orthotic device and manual probe fixation methods were moderate ( = 0.486-0.718; < 0.05). Bland-Altman plots indicated adequate agreement between both measurement methods according to the agreement limits. The proposed novel thoracic orthotic device may allow ultrasound probe fixation to provide valid and reliable transcostal RUSI measurements of diaphragmatic thickness during relaxed breathing thus reducing some measurement errors and avoiding systematic measurement errors. It may be advisable to measure diaphragm thickness and facilitate visual biofeedback with respect to diaphragm re-education during normal breathing in athletes with non-specific lumbopelvic pain.
Kinesiophobia Levels in Patients with Parkinson’s Disease: A Case-Control Investigation
(International Journal of Environmental Research and Public Health, 2021) Jiménez Cebrián, Ana María; Becerro de Bengoa Vallejo, Ricardo; Losa Iglesias, Marta Elena; Labra, Carmen de; Calvo Lobo, César; Palomo López, Patricia; Martínez Jiménez, Eva María; Navarro Flores, Emmanuel
Background: Kinesiophobia can be an obstacle to physical and motor activity in patients with Parkinson’s disease (PD). PD affects patients’ independence in carrying out daily activities. It also impacts a patient’s biopsychosocial well-being. The objective of this study was to analyze the levels and scores of kinesiophobia in PD patients and compare them with healthy volunteers. Methods: We deployed a case-control study and recruited 124 subjects (mean age 69.18 ± 9.12). PD patients were recruited from a center of excellence for Parkinson’s disease (cases n = 62). Control subjects were recruited from the same hospital (control n = 62). Kinesiophobia total scores and categories were self-reported using the Spanish version of the Tampa Scale of Kinesiophobia (TSK-11). Results: Differences between cases and control groups were analyzed using the Mann–Whitney U test. Statistically significant differences (p < 0.05) were shown between groups when comparing kinesiophobia categories (or levels) and total scores, revealing higher kinesiophobia symptoms and levels in PD patients. All of the PD patients reported some degree of kinesiophobia (TSK-11 ≥ 18), while the majority of PD patients (77.3%) had kinesiophobia scores rated as moderate to severe (TSK-11 ≥ 25). On the other hand, ~45.1% of controls reported no or slight kinesiophobia and 53.2% reported moderate kinesiophobia. Conclusions: Total kinesiophobia scores were significantly higher in PD patients compared with healthy controls, with moderate to severe kinesiophobia levels prevailing in PD patients. Therefore, individuals living with PD should be evaluated and controlled in order to detect initial kinesiophobia symptoms.
The Impact of Depression Symptoms in Patients with Parkinson’s Disease: A Novel Case-Control Investigation
(International Journal of Environmental Research and Public Health, 2021) Jiménez Cebrián, Ana; Becerro de Bengoa Vallejo, Ricardo; Losa Iglesias, Marta Elena; López López, Daniel; Calvo Lobo, César; Palomo López, Patricia; Romero Morales, Carlos; Navarro Flores, Emmanuel
Parkinson’s disease is a common neurodegenerative disease and it is known to cause motor disturbances associated with musculoskeletal problems of the locomotor apparatus, and non-motor symptoms, that are believed to have a harmful effect on health, social functioning and mobility. The aim of this study was to evaluate depression in patients with Parkinson’s Disease (PD) compared to subjects who do not have it. The sample consisted of 124 participants (mean age 69.18 ± 9.12). Patients with PD were recruited from a center of excellence for Parkinson’s disease (cases n = 62) and healthy subjects without PD from their relatives and caregivers (control n = 62). The Spanish version of Beck’s Depression Inventory (BDI) scores and categories were collected. A clear statistically significant difference (p < 0.05) was evident in the BDI scores between both groups. Parkinson’s patients presented worse results on the BDI = 15.48 ± 7.24 points compared to healthy subjects with BDI = 7.03 ± 6.99 points. Regarding BDI categories, there were statistically significant differences (p < 0.001) for the greater BDI categories in the Parkinson’s group compared with healthy subjects. The depression represents an important potential risk for increased symptoms and negative impact among patients with PD compared with healthy subjects.
Effectiveness of Custom Foot Insoles to Decrease Plantar Pressure: A Cross-over Randomized Trial Study
(Healthcare, 2022) Casado Hernández, Israel; Becerro de Bengoa Vallejo, Ricardo; Losa Iglesias, Marta Elena; Cosín Matamoros, Julia María; Calvo Lobo, César; Rodríguez Sanz, David; López López, Daniel; Martínez Jiménez, Eva María
Background: Harderness insoles decrease plantar pressure and reduce the foot injury incidence in sport. The purpose of our study was to analyze the plantar pressure variation in moto riders after riding in a real speed circuit with a custom foot 520 Shore EVA insole. Methods: A crossover randomized trial study was performed (consent no. #050520165316). Riders were assessed by an expert motorsport senior podiatry. The participants’ mean age was 35 ± 3.29. Participants completed a 20 min training riding with their own motorcycle in a real speed circuit. Plantar pressures were registered with a baropodometric platform evaluating an Ethyl Vinyl Acetate custom foot insole (CFI) manufactured with 3 mm thickness and 52° Shore A hardness. The Plantar pressures were registered before riding, after riding without EVA insole, and after riding with EVA insole. Results: Total Plantar pressures in right and left foot, and total surface area decrease after riding with EVA insoles. Conclusion: The use of an EVA insole with 520 shore A hardness riding on a motorcycle in speed circuit decreased the total plantar pressures and surface areas values.
Effectiveness of Ultrasonography Visual Biofeedback of the Diaphragm in Conjunction with Inspiratory Muscle Training on Muscle Thickness, Respiratory Pressures, Pain, Disability, Quality of Life and Pulmonary Function in Athletes with Non-Specific Low Back Pain: A Randomized Clinical Trial
(Journal of Clinical Medicine, 2022) Marugán Rubio, Daniel; Chicharro, José López; Becerro de Bengoa Vallejo, Ricardo; Losa Iglesias, Marta Elena; Rodríguez Sanz, David; Vicente Campos, Davinia; Molina Hernández, Nerea; Calvo Lobo, César
Diaphragmatic weakness and thickness reduction have been detected in athletes with lumbopelvic pain (LPP). Strength training of inspiratory muscles may be necessary for athletes with LPP. Inspiratory muscle training (IMT) and visual biofeedback by rehabilitative ultrasound imaging (RUSI) have been proposed as possible interventions. Here, we determine the effectiveness of visual biofeedback by RUSI with a proposed novel thoracic orthotic device to facilitate diaphragmatic contraction in conjunction with high-intensity IMT in athletes with non-specific LPP. A single-blinded, parallel-group, randomized clinical trial was performed (NCT04097873). Of 86 participants assessed for eligibility, 64 athletes with non-specific LPP (39 males and 25 females; mean age, 33.15 ± 7.79 years) were recruited, randomized, analyzed and received diaphragm visual biofeedback by RUSI in conjunction with high-intensity IMT (RUSI+IMT; n = 32) or isolated high-intensity IMT (IMT; n = 32) interventions for 8 weeks. Diaphragmatic thickness during normal breathing, maximum respiratory pressures, pain intensity, pressure pain threshold on lumbar musculature, disability by the Roland–Morris questionnaire, quality of life by the SF-12 questionnaire and spirometry respiratory parameters were assessed at baseline and after the 8-week intervention. There were significant differences (p = 0.015), within a medium effect size (Cohen’s d = 0.62) for the forced expiratory volume in 1-s (FEV1), which was increased in the RUSI+IMT intervention group relative to the IMT alone group. Adverse effects were not observed. The rest of the outcomes did not show significant differences (p > 0.05). Diaphragm visual biofeedback by RUSI with the proposed novel thoracic orthotic device in conjunction with high-intensity IMT improved lung function by increasing FEV1 in athletes with non-specific LPP.
Effect of the cushioning running shoes in ground contact time of phases of gait
(Journal of the mechanical behavior of biomedical materials., 2018) Roca Dols, Andrea; Losa Iglesias, Marta Elena; Sánchez Gómez, Rubén; Becerro De Bengoa Vallejo, Ricardo; López López, Daniel; Rodríguez Sanz, David; Martínez Jiménez, Eva María; Calvo Lobo, César
The main objective of this research was to know how five different cushioning shoes may interfere in ground contact times of each gait phase of walking and running in contrast with barefoot condition. Thirty healthy sport recreational male runners participated in this study. They played over a treadmill wearing minimalist, Boost®, Ethyl-vinyl-acetate (EVA), Air® chamber and pronation-control cushioning shoes technologies and under barefoot condition, recording the last 30 s of walking and running at 5.17 km/h and 9 km/h respectively, while ground contact time duration of each phase of gait was recorded with circular standard pressure sensors located on plantar feet. During walking, the heel contact phase was the station that increased significantly ground contact times wearing all sole cushioning shoes (p < 0.001), excepting no sole shoes (minimalist), versus barefoot condition, being Air® chamber the model that showed the highest times of contact floor versus barefoot (0.28 ± 0.08 ms and 0.23 ± 0.12 ms vs 0.12 ± 0.07 ms and 0.18 ± 0.07 ms in heel contact during midstance phases, respectively). During running, propulsion phase was the station that showed the highest spent times on ground contact with the floor under all shoe conditions, even with minimalist, being again Air® chamber the model with higher significant times in two of three phases versus barefoot (0.11 ± 0.04 ms and 0.16 ± 0.11 ms vs 0.09 ± 0.03 ms and 0.10 ± 0.02 ms in midstance and propulsion phases respectively). Air chamber® was the model too with the most switch ratio to forefoot strike pattern (0.07 ± 0.10 ms to 0.16 ± 0.11 from heel contact to propulsion phase, respectively). In conclusion, a ground contact times increase using all cushioning running shoes compared with barefoot condition was shown in both walking and running test.
Effect of Foot Orthoses and Shoes in Parkinson’s Disease Patients: A PRISMA Systematic Review
(Journal of Personalized Medicine, 2021) Reina Bueno, María; Calvo Lobo, César; López López, Daniel; Palomo López, Patricia; Becerro de Bengoa Vallejo, Ricardo; Losa Iglesias, Marta Elena; Romero Morales, Carlos; Navarro Flores, Emmanuel
Reduced plantar foot sensation, postural instability, and gait difficulties are characteristic of Parkinson´s disease patients. A systematic review was carried out to determine the effect of the different types of insoles and shoes in these patients. Several databases were used to search for relevant articles reporting Parkinson´s disease patients undergoing treatment with any type of insole and footwear. All titles and abstracts were reviewed independently by two reviewers and the available data were extracted. The study eligibility criteria were any type of experimental study that included Parkinson’s disease patients treated with any type of insole or footwear. Eight studies were selected. Interventions used were textured insoles, footwear modifications, and habitual footwear. Three different outcomes were evaluated in each study: gait parameters, balance, and plantar sensation. According to the data available from this systematic review, the most important conclusion is that more controlled studies are needed in this research field. There are indications to suggest that textured insoles have positive effects on gait parameters, balance, and plantar sensation in Parkinson’s disease patients.
An Automated Blood Pressure Display for Self-Measurement in Patients with Chronic Kidney Disease (iHealth Track): Device Validation Study
(JMIR mHealth and uHealth, 2020) Mazoteras Pardo, Victoria; Becerro De Bengoa Vallejo, Ricardo; Losa Iglesias, Marta Elena; López López, Daniel; Calvo Lobo, César; Rodríguez Sanz, David; Martínez Jiménez, Eva María; Palomo López Patricia
Background: Hypertension is a global public health issue and is closely related to chronic kidney disorder (CKD). In people with CKD, strict monitoring of blood pressure is an important part of therapy. Objective: The aim of this research was to validate the iHealth Track blood pressure monitoring device for patients with CKD according to the European Society of Hypertension International Protocol 2010 (ESH-IP2). Methods: In total, 33 patients who received hemodialysis in Plasencia participated in the study. There were 9 successive measurements made, which conformed to the ESH-IP2. We calculated the differences between the standard reference device (Omron M3 Intellisense) and the test device (iHealth Track) for blood pressure and heart rate values. For 99 total comparisons of paired measurements, we classified differences into various categories (≤5 mmHg, ≤10 mmHg, and ≤15 mmHg for blood pressure; ≤3, ≤5, and ≤8 beats per minute for heart rate). Results: In 90 of 99 systolic blood pressure and 89 of 99 diastolic blood pressure comparisons between the devices, measurement differences were within 5 mmHg. In 81 of 99 heart rate comparisons between the devices, measurement differences were within 3 beats per minute. The mean differences between the test and reference standard measurements were 3.27 (SD 2.99) mmHg for systolic blood pressure, 3.59 (SD 4.55) mmHg for diastolic blood pressure, and 2.18 (SD 2.75) beats per minute for heart rate. We also observed that for both systolic and diastolic blood pressure, 31 of 33 participants had at least two of three comparisons between the devices with measurement differences less than 5 mmHg. For heart rate, 28 of 33 patients had at least two of three comparisons between the devices with measurement differences less than 3 beats per minute. Conclusions: To our knowledge, this is the first study to show that iHealth Track meets the requirements of the ESH-IP2 in patients with CKD. Therefore, the iHealth Track is suitable for use in renal patients.
QardioArm(R) Blood pressure monitoring in a population with Type 2 diabetes: Validation Study.
(Journal of Medical Internet Research, 2020) Mazoteras Pardo, Victoria; Becerro De Bengoa Vallejo, Ricardo; Losa Iglesias, Marta Elena; Martínez Jiménez, Eva María; Calvo Lobo, César; Romero Morales, Carlos; López López, Daniel; Palomo Lopez, Patricia
Background: Home blood pressure monitoring has many benefits, even more so, in populations prone to high blood pressure, such as persons with diabetes. Objective: The purpose of this research was to validate the QardioArm mobile device in a sample of individuals with noninsulin-dependent type 2 diabetes in accordance with the guidelines of the second International Protocol of the European Society of Hypertension. Methods: The sample consisted of 33 patients with type 2 diabetes. To evaluate the validity of QardioArm by comparing its data with that obtained with a digital sphygmomanometer (Omron M3 Intellisense), two nurses collected diastolic blood pressure, systolic blood pressure, and heart rate with both devices. Results: The analysis indicated that the test device QardioArm met all the validation requirements using a sample population with type 2 diabetes. Conclusions: This paper reports the first validation of QardioArm in a population of individuals with noninsulin-dependent type 2 diabetes. QardioArm for home monitoring of blood pressure and heart rate met the requirements of the second International Protocol of the European Society of Hypertension.